XSHG
688639
, Last price
Name
Anhui Huaheng Biotechnology Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Anhui Huaheng Biotechnology Co., Ltd. specializes in the research, manufacturing, and international distribution of amino acids and various organic acids. The company's product range encompasses L-alanine, DL-alanine, beta-alanine, and D-alanine, as well as L-aspartic, DL-aspartic, D-aspartic acids, and L-aspartate salt. Additionally, it provides an array of other amino acids and arbutin products. These ingredients are widely utilized in pharmaceuticals, healthcare goods, food and food additives, daily personal care items, and other diverse industrial applications. Founded in Hefei, China, in 2005, the company operated as Anhui Huaheng Biological Engineering Co., Ltd. until its name officially changed to Anhui Huaheng Biotechnology Co., Ltd. in November 2013.
Key people
Yi Fan
Finance Director, Deputy General Manager, Secretary of the Board, Director · since 2016
Henghua Guo
Chairman of the Board, General Manager · since 2013
Fanbao Meng
Deputy General Manager · since 2016
Siqing Tang
Deputy General Manager · since 2013
Dongzhu Zhang
Deputy General Manager, Director · since 2007
Hengping Guo
Director · since 2013
Yunzhong Shi
Director · since 2014
Xueli Zhang
Director · since 2013
Shimin Chen
Independent Director
Shuguang Zhang
Independent Director
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||